So the idea was to bring it back into research, number one, and that happened. The first study was completed, and it was found of 20 people that had treatment-resistant post-traumatic stress disorder, primarily from rape, sexual abuse, and early childhood trauma, mostly women, that 83% no longer had post-traumatic stress after taking MDMA with therapy for 2 or 3 times.
That's the protocol. The protocol only calls for the use of the drugs two to three times, along with therapy prior to the drug experience and in between the drug experiences. So it's a very light touch on the drug and a very light touch on the therapy as well, actually. It's a very hands-off kind of thing, where the therapist acts as guide, based on the therapy that's been done with Stan Grof, the work that has been done for years on psychedelic therapy.
That the intent going in is important. The setting is important. You do it in comfortable places that are safe, that are quiet, that are more like a living room situation than a doctor's office. And then the therapist is there to make sure to find the inner healer within the person under therapy. Michael Mithoefer, the therapist that has developed the protocol, primarily the lead therapist on the protocol development, has said that it is like penicillin. You use penicillin, and then the body heals itself. The body knows how to heal itself. Well, that's also true with this therapy. The idea is that the individual knows how to heal themselves, and they just need a little bit of a break from the trauma or the wounds that the trauma has caused, so that they can heal themselves.
So the first study did find incredible results, very, very strong results. Eighty three percent no longer having Post-Traumatic Stress Disorder is highly unusual. Other drugs, Zoloft and the antidepressants, they get about a 7%, but of course, they've been through the entire phase two and phase three clinical trial process.
We have only done one completed study, and we have four currently running now. They're all showing similar results. We have a veteran study, a study with only veterans. So the first study was mostly women from sexual abuse and childhood trauma. This second study, we thought, "Well, is it gonna work for veterans as well?" And so the study includes veterans, police officers, and firefighters. And we are enrolling the last couple. It'll be a study of 25 patients, subjects. That's just about over. It'll be over this summer.
That's the protocol. The protocol only calls for the use of the drugs two to three times, along with therapy prior to the drug experience and in between the drug experiences. So it's a very light touch on the drug and a very light touch on the therapy as well, actually. It's a very hands-off kind of thing, where the therapist acts as guide, based on the therapy that's been done with Stan Grof, the work that has been done for years on psychedelic therapy.
That the intent going in is important. The setting is important. You do it in comfortable places that are safe, that are quiet, that are more like a living room situation than a doctor's office. And then the therapist is there to make sure to find the inner healer within the person under therapy. Michael Mithoefer, the therapist that has developed the protocol, primarily the lead therapist on the protocol development, has said that it is like penicillin. You use penicillin, and then the body heals itself. The body knows how to heal itself. Well, that's also true with this therapy. The idea is that the individual knows how to heal themselves, and they just need a little bit of a break from the trauma or the wounds that the trauma has caused, so that they can heal themselves.
So the first study did find incredible results, very, very strong results. Eighty three percent no longer having Post-Traumatic Stress Disorder is highly unusual. Other drugs, Zoloft and the antidepressants, they get about a 7%, but of course, they've been through the entire phase two and phase three clinical trial process.
We have only done one completed study, and we have four currently running now. They're all showing similar results. We have a veteran study, a study with only veterans. So the first study was mostly women from sexual abuse and childhood trauma. This second study, we thought, "Well, is it gonna work for veterans as well?" And so the study includes veterans, police officers, and firefighters. And we are enrolling the last couple. It'll be a study of 25 patients, subjects. That's just about over. It'll be over this summer.
